COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,609 Articles (22,913 medRxiv, 8,696 bioRxiv)

Most recent first Previous |  Page 795: Articles 7941-7950  | Next

Severe acute respiratory syndrome coronavirus 2 breakthrough infections in healthcare workers vaccinees with BNT162b2 (Pfizer-BioNtech) in Bogota, Colombia
Tavera-Rodriguez, P., Barbosa-Ramirez, J., Bermudez-Forero, A., Prada-Cardozo, D., Reales-Gonzalez, J., Pelaez-Carvajal, D., Malo-Sanchez, D., Meneses-Gil, M.-X., Mercado-Reyes, M.
10.1101/2022.05.31.22274501 — Posted: 2022-06-01
Antiviral immune responses, cellular metabolism and adhesion are differentially modulated by SARS-CoV-2 ORF7a or ORF7b
Garcia-Garcia, T., Fernandez-Rodriguez, R., Redondo, N., de Lucas-Rius, A., Zaldivar-Lopez, S., Dies Lopez-Ayllon, B., Suarez-Cardenas, J. M., Jimenez-Marin, A., Montoya, M., Garrido, J. J.
10.1101/2022.06.01.494101 — Posted: 2022-06-01
SUMOylation of SARS-CoV-2 Nucleocapsid protein enhances its interaction affinity and plays a critical role for its nuclear translocation
Liao, J., Madahar, V., Rodgers, V. G. J.
10.1101/2022.05.31.494262 — Posted: 2022-06-01
Anti-COVID-19 Activity of FDA Approved Drugs through RNA G-quadruplex Binding
Roy, S. S., Sharma, S., Rizvi, Z. A., Sinha, D., Gupta, D., Rophina, M., Sehgal, P., Sadhu, S., Tripathy, M. R., Samal, S., Maiti, S., Scaria, V., Sivasubbu, S., Awasthi, A., Harshan, K., Jain, S., Chowdhury, S.
10.1101/2022.05.31.493843 — Posted: 2022-06-01
SARS-CoV-2 Variant Spike and accessory gene mutations alter pathogenesis
McGrath, M., Xue, Y., Dillen, C., Oldfield, L., Assad-Garcia, N., Zaveri, J., Singh, N., Baracco, L., Taylor, L., Vashee, S., Frieman, M.
10.1101/2022.05.31.494211 — Posted: 2022-06-01
Plasmacytoid dendritic cells regulate megakaryocyte and platelet homeostasis
Gaertner, F., Ishikawa-Ankerhold, H., Stutte, S., Fu, W., Guo, C., Weitz, J., Dueck, A., Zhang, Z., van den Heuvel, D., Fumagalli, V., Lorenz, M., von Baumgarten, L., Stark, K., Straub, T., von Stillfried, S., Boor, P., Colonna, M., Schulz, C., Brocker, T., Walzog, B., Scheiermann, C., Engelhardt, S., Aird, W. C., Petzold, T., Sixt, M., Rudelius, M., Nerlov, C., Iannacone, M., Oostendorp, R. A. J., Massberg, S.
10.1101/2022.05.31.494147 — Posted: 2022-06-01
Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults
Liu, X., Li, Y., Wang, Z., Cao, S., Huang, W., Yuan, L., Huang, Y.-J., Zheng, Y., Chen, J., Ying, B., Xiang, Z., Shi, J., Zhao, J., Huang, Z., Qin, C.-F.
10.1101/2022.05.30.22275753 — Posted: 2022-05-31
Lineage BA.2 dominated the Omicron SARS-CoV-2 epidemic wave in the Philippines
Li, Y.-T., Polotan, F. G. M., Sotelo, G. I. S., Alpino, A. P. A., Dolor, A. Y. M., Tujan, M. A. A., Gomez, M. R. R., Onza, O. J. T., Chang, A. K. T., Bautista, C. T., Carandang, J. C., Lim, D. R., Dancel, L. L. M., Lumandas, M. U., Dizon, T. J. R., Hampson, K., Daldry, S., Hughes, J., Brunker, K.
10.1101/2022.05.30.22275783 — Posted: 2022-05-31
Immunity response against mild-to-moderate breakthrough COVID-19
Mongkolsucharitkul, P., Surawit, A., Sookrung, N., Tungtrongchitr, A., Phisalprapa, P., Sayabovorn, N., Srivanichakorn, W., Washirasaksiri, C., Auesomwang, C., Sitasuwan, T., Chaisathaphol, T., Tinmanee, R., Chayakulkeeree, M., Phoompoung, P., Tangjittipokin, W., Senawong, S., Sanpawitayakul, G., Muangman, S., Mayurasakorn, K.
10.1101/2022.05.30.22275050 — Posted: 2022-05-31
The cost of the COVID-19 pandemic vs the cost-effectiveness of mitigation strategies in the EU/UK/EEA and OECD countries: a systematic review
Vardavas, C., Zisis, K., Nikitara, K., Lagou, I., Aslanoglou, K., Athanasakis, K., Phalkey, R., Leonardi-Bee, J., Fernandez, E., Condell, O., Lamb, F., Sandmann, F., Pharris, A., Deogan, C., Suk, J. E.
10.1101/2022.05.31.22275813 — Posted: 2022-05-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).